D-0313-2024 Class III Ongoing
FDA drug recall D-0313-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 18, 2024 and is designated Class III. Reason for recall: Misprint on tablet The recall status is ongoing. Affected quantity: 14,425 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 14, 2024
- Initiation Date
- Jan 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,425 bottles
Product Description
Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05
Reason for Recall
Misprint on tablet
Distribution Pattern
Nationwide
Code Information
Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0313-2024
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026